Filing Details

Accession Number:
0001209191-21-053523
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-26 17:54:36
Reporting Period:
2021-08-25
Accepted Time:
2021-08-26 17:54:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1637715 Reneo Pharmaceuticals Inc. RPHM Pharmaceutical Preparations (2834) 472309515
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1855115 R. Vineet Jindal C/O Reneo Pharmaceuticals, Inc.
18575 Jamboree Road, Suite 275-S
Irvine CA 92612
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-25 5,000 $7.44 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average purchase price for the transaction was $7.4353. The shares were purchased at a range of prices between $7.39 and $7.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.